J&J Talc Cancer MDL: What Johnson & Johnson’s Motion to Dismiss Means for Your Claim
You used a product your whole life that was sold to you as safe — pure, gentle, meant for babies — and now you are sitting with an ovarian cancer diagnosis, or you are sitting where your mother used to sit, and she is gone. You heard that Johnson & Johnson just filed something in court that sounds like it could end everyone’s case at once. You are reading this at 2 a.m. because you cannot sleep, and you need to know whether your case — or your mother’s case — just disappeared.
It did not. Here is what actually happened, what it means, and what you should do about it.
We are Attorney911 — The Manginello Law Firm. Ralph Manginello has spent 27-plus years in courtrooms, including federal court, and before he was a lawyer he was a journalist, which means he reads a court filing and tells you what it actually says, not what someone wants you to hear. Lupe Peña sat on the other side of the table for years inside a national insurance-defense firm — the rooms where claims are valued, delayed, and devalued — and now he uses that knowledge for injured people. We handle toxic tort and product liability cases nationwide, and we are writing this because the news headlines about J&J’s motion are scaring people who deserve a straight answer.
What Just Happened: J&J’s Motion to Dismiss, in Plain English
Johnson & Johnson filed a motion in the U.S. District Court for the District of New Jersey — the federal court where the talc multidistrict litigation has been managed for years — asking the judge to dismiss the entire consolidated docket. The motion asks the court to direct plaintiffs to show cause why their allegations should not be dismissed with prejudice.
That phrase — “with prejudice” — is the part that sounds terrifying, and it is serious. “Dismissed with prejudice” means a case is permanently barred. It cannot be refiled. It is over. If the court granted J&J’s motion across the board, every pending talc-ovarian cancer claim in the MDL would be extinguished in a single order.
But a motion is not a ruling. A motion is a request. J&J is asking the court to do this. The court has not done it. Plaintiffs’ counsel across the country are preparing responses, and the fight over this motion is just beginning.
As of mid-2026, the talc MDL — formally numbered MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — contained more than 68,000 pending actions consolidated before Judge Michael A. Shipp in the District of New Jersey. That is not a typo. More than 68,000 individual women and families have claims consolidated in that one courtroom, each alleging that J&J’s talc-based products — including the baby powder that sat on American bathroom shelves for over a century — caused ovarian cancer.
J&J’s filing represents a shift in strategy. For a decade, the company has been settling some cases, trying others, and attempting to channel the entire docket into bankruptcy through a corporate restructuring maneuver called the “Texas Two-Step.” That bankruptcy strategy failed three times. Now the company is back in the tort system, and its next move is to try to end the litigation not case-by-case, but in one sweep — by arguing that the scientific evidence connecting talc to ovarian cancer does not meet the legal standard for admissibility.
What “Dismissed With Prejudice” Actually Means — and Why It Matters
A dismissal “without prejudice” means the case is closed but can be refiled. A dismissal “with prejudice” means the case is dead permanently. It is the legal equivalent of a door being welded shut.
J&J is seeking dismissal with prejudice because it wants finality. The company does not want to fight 68,000 individual cases. It wants a single ruling that eliminates the entire docket — or at least the vast majority of it — in one stroke.
The most likely legal basis for the motion is a challenge to general causation — the question of whether talc exposure can cause ovarian cancer at all, as a matter of science. If the court rules that the scientific evidence is not reliable enough to go to a jury, then no individual plaintiff’s case can survive, because every case depends on that foundational link. This is typically fought through a Daubert motion — a request to exclude expert testimony under the federal standard for scientific evidence — followed by a summary judgment motion arguing that without admissible expert testimony, no plaintiff can prove causation.
This is the single most dangerous procedural maneuver in mass tort litigation. If it succeeds, it does not matter how strong any individual plaintiff’s exposure history is, or how devastating their cancer diagnosis is, or how damning J&J’s internal documents are. If the general causation evidence is excluded, the cases fall.
But here is what the defense does not want you to know: Daubert challenges in mass tort MDLs frequently fail. The standard for admissibility is not whether the science is certain — it is whether the expert’s methodology is reliable and whether the testimony will help the jury. Epidemiological studies showing a statistically significant association between perineal talc use and ovarian cancer, combined with toxicological evidence of talc particles migrating to ovarian tissue, internal corporate documents showing decades of awareness, and the classification of perineal talc use by the International Agency for Research on Cancer, together form a body of evidence that plaintiffs’ experts will argue meets the reliability standard.
“The International Agency for Research on Cancer classifies perineal use of talc-based body powder as possibly carcinogenic to humans.”
That classification — from the world’s leading cancer research authority — is not a plaintiff’s lawyer’s argument. It is a published scientific determination by an agency of the World Health Organization. It is one of the foundational pieces of evidence that plaintiffs will cite in response to J&J’s motion.
The J&J Corporate Structure: Who You Are Really Fighting
One of the first things we do in any toxic exposure case is figure out who the actual defendant is — not the name on the baby powder bottle, but the legal entity that manufactured, marketed, and is now defending the product. Johnson & Johnson is not a single company. It is a web of entities, and the talc liability has been shuffled through several of them.
The parent corporation is Johnson & Johnson. The historical talc seller was Johnson & Johnson Consumer Inc. (JJCI). When J&J attempted its bankruptcy strategy, it created a shell entity called LTL Management LLC to hold the talc liability — that entity filed Chapter 11 twice and was dismissed twice. A third attempt used a renamed entity called Red River Talc LLC, which also filed bankruptcy and was dismissed on March 31, 2025, by the U.S. Bankruptcy Court for the Southern District of Texas. Three attempts. Three failures. The cases are back in the tort system.
In 2023, J&J spun off its consumer health business into a separate publicly traded company called Kenvue Inc. — the entity that now owns brands like Band-Aid, Tylenol, and Listerine. J&J retained indemnity obligations for talc liability, but the corporate restructuring means the entity that sold the powder and the entity that answers for it in court may not be the same company that holds the assets.
This matters because naming the wrong defendant — or failing to name the right one — can kill a case before it starts. Corporate successor liability analysis is required to determine which entity assumed the talc product liabilities after the spinoff, and whether the parent’s indemnity arrangements are sufficient to satisfy judgments. Upstream talc suppliers — the mining and processing companies whose raw material entered J&J’s manufacturing stream — may also be defendants if asbestos contamination is part of the theory, because asbestos is a known human carcinogen and its presence in a cosmetic product would constitute adulteration under federal law.
The Theories of Liability: Five Ways These Cases Are Built
Every talc-ovarian cancer case in the MDL is built on one or more of five legal theories. Understanding them matters because J&J’s dismissal motion targets the evidence that supports all of them.
Failure to warn is the core theory. J&J knew or should have known of the association between perineal talc use and ovarian cancer but failed to provide adequate consumer warnings for decades. The evidentiary spine here is internal corporate documents — testing results, safety committee minutes, marketing strategy records, and regulatory correspondence that show what the company knew and when. If the jury sees documents showing J&J was aware of cancer concerns and chose to market baby powder for feminine hygiene without warning, that is not just liability — it is the predicate for punitive damages.
Design defect argues that talc-based feminine hygiene products were unreasonably dangerous as designed, given the known risk profile of talc application to the genital area and the availability of cornstarch-based alternatives. A product that can be made safer with a substitute ingredient that is already on the market is a product that may be defective by design.
Manufacturing defect and adulteration applies where talc products were contaminated with asbestos. Talc and asbestos are geologically related minerals that can be found in the same mines. If talc products contained asbestos — even trace amounts — they were adulterated under the Federal Food, Drug, and Cosmetic Act, and the contamination constitutes a manufacturing defect under state product liability law. J&J discontinued talc-based baby powder in North America, which is itself a fact a jury can consider.
Fraudulent misrepresentation and concealment covers J&J’s decades-long marketing of baby powder as safe for feminine hygiene, potentially despite internal awareness of cancer risks. This theory supports claims of intentional concealment and consumer fraud — and it is the engine behind punitive damages. A company that studies a risk, confirms it, and markets the product as safe anyway is not just negligent. It is a company that made a choice.
Strict products liability means J&J is liable for placing a defective product into the stream of commerce regardless of negligence. The defect may be in design, manufacture, or warning adequacy. The plaintiff does not need to prove J&J was careless — only that the product was defective and caused the injury.
The Regulatory Gap: Why Cosmetics Are Not Pre-Approved
One of the things that makes the talc litigation so striking is the regulatory backdrop. Most people assume the government tested these products and approved them before they reached the shelf. That assumption is wrong.
“The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act but does not require pre-market approval for cosmetics, including talc-based powders; manufacturers bear responsibility for product safety and adequate labeling.”
The FDA does not pre-approve cosmetics. The manufacturer is responsible for safety — and for labeling. There is no government testing requirement before a cosmetic product reaches consumers. The FDA can act after the fact — it can survey products, test for asbestos, and take enforcement action against adulterated products — but the front-end gatekeeping that most Americans assume exists for products they put on their bodies simply does not exist for cosmetics.
The FDA has conducted surveys testing cosmetic talc products for asbestos contamination. Products found to contain asbestos would be deemed adulterated under the FDCA, creating a potential negligence-per-se pathway where contamination is demonstrated. But the absence of a pre-market approval regime means the question of whether talc is safe for perineal use was left largely to the manufacturer to study, to know, and to warn about — and the plaintiffs’ position is that J&J studied it, knew, and did not warn.
This regulatory gap is not a defense for J&J. It is part of the case against it. When the law puts responsibility for safety on the manufacturer, and the manufacturer allegedly fails to meet that responsibility, the regulatory framework becomes the standard of care the plaintiff argues was breached.
The Evidence Clock: What Is Disappearing While You Wait
If you or a loved one used talc products and developed ovarian cancer, evidence is aging and disappearing right now. Some of it is on a clock you cannot stop without legal action. Here is what exists, who holds it, and how fast it can disappear.
Your medical records — pathology reports, oncology treatment records, diagnostic imaging — are generally stable in provider systems, but hospitals and clinics operate on retention schedules that can purge records after a set number of years. The older your diagnosis, the higher the risk that records have been thinned or destroyed. Obtain your complete medical file now, not later. Your pathology report matters more than almost any other document — it establishes your cancer diagnosis, the histological subtype, staging, treatment course, and prognosis. This is the foundation of damages and specific causation.
Your talc product usage history is the exposure element — and it is perishable in a way medical records are not. Purchase receipts, product containers, and family testimony about your usage habits are the proof of how long, how often, and which brand you used. Memories fade. Physical containers are discarded. If you still have a bottle of J&J baby powder — or any talc product — with a lot number visible, do not throw it away. Product containers with lot numbers may enable batch-specific testing for asbestos contamination. That container is evidence.
J&J internal corporate documents — testing results, safety committee minutes, marketing strategy records, regulatory correspondence — are already in MDL discovery production. These documents are the core of the failure-to-warn and punitive damages case. They show corporate knowledge of cancer risk and deliberate marketing decisions. Ongoing document retention and any supplemental production must be monitored, but the existing discovery record is largely preserved in the MDL.
Talc product samples for independent testing are finite and irreplaceable. J&J discontinued talc-based baby powder in North America. Remaining product samples — whether in your bathroom cabinet or in evidence storage — are a limited resource. If independent mineralogical testing for asbestos contamination is part of your case theory, the product sample is the evidence that makes that testing possible.
Expert causation opinions — epidemiological, oncological, toxicological, and geological — are under attack. J&J’s motion to dismiss is built on challenging these opinions. The evolving scientific literature requires experts to maintain current opinions, and the Daubert fight over whether those opinions are admissible is the central battleground of the dismissal motion. Your case depends on whether your experts survive that challenge.
The preservation letter — a formal demand that evidence be frozen — is the tool that stops the clock on records the defendant or third parties hold. In a mass tort MDL, many of these demands are handled at the leadership level, but individual evidence — your medical records, your product containers, your family’s testimony about your usage — is yours to preserve or lose.
How Much Is a Talc Cancer Case Worth?
We are not going to tell you a number and call it a promise. That would be dishonest. What we can tell you is how the value is built and what the verified track record shows.
Individual talc-ovarian cancer claims in this MDL span an exceptionally wide range depending on the strength of specific causation proof, the duration and frequency of genital talc use, the plaintiff’s age and cancer stage, and the governing state law. Cases with the strongest specific causation profiles — long-term, high-frequency perineal talc use, early-onset ovarian cancer, BRCA-negative status, and minimal alternative risk factors — carry the highest individual value. Cases with weaker exposure documentation or significant alternative risk factors carry lower value.
Bellwether trials in the talc litigation have produced verdicts ranging from multi-million-dollar individual awards to aggregate judgments in the billions. The most closely watched verdict — Ingham v. Johnson & Johnson, tried in Missouri state court — produced a jury award of $4.69 billion in July 2018 for 22 plaintiffs. On appeal, the Missouri Court of Appeals reduced that to approximately $2.12 billion in June 2020. The U.S. Supreme Court denied certiorari on June 1, 2021, meaning the reduced award stands as final. That is not a press release number — it is a verified, affirmed judgment that the highest court in the country declined to disturb.
But that verdict does not predict what your case is worth. Your case value depends on your specific facts: your exposure history, your cancer diagnosis and stage, your treatment trajectory, your age and earning capacity, the strength of your specific causation evidence, and the governing state law — including whether that state caps non-economic or punitive damages.
The damages categories in these cases include:
- Past and future medical treatment — surgical intervention, chemotherapy, radiation, ongoing oncological monitoring
- Lost wages and diminished earning capacity — the income you lost during treatment and the income you will never earn because of your illness
- Non-economic damages — physical pain, emotional distress, loss of quality of life, disfigurement
- Wrongful death and survival damages — where the plaintiff has died, the estate’s claim for the decedent’s suffering between injury and death, and the family’s claim under the applicable state’s wrongful death statute
- Punitive damages — where evidence demonstrates J&J’s decades-long knowledge of cancer risk combined with continued marketing without adequate warnings
Punitive damages are a central pillar of these cases. The concealment-and-knowledge pattern — if proven — is the engine that drives punitive exposure. But punitive damage availability and any statutory caps vary significantly by the plaintiff’s governing state law. Some states cap punitive damages. Some cap non-economic damages. Some have no caps at all. The governing law is determined on a plaintiff-by-plaintiff basis according to each claimant’s home state law or the law of the state where exposure and injury occurred.
If you want to understand how wrongful death claims work when the person who was exposed has passed, our wrongful death practice page walks through the machinery families face — the personal representative appointment, the survival action, the wrongful death beneficiaries, and the difference between the two claims.
The Defense Playbook: What J&J Will Try
J&J’s defense is not a mystery. It follows a playbook that mass tort defendants have run for decades, refined by one of the most sophisticated corporate defense bars in the world. Here are the plays and the counters.
Play 1: The Daubert Sweep. J&J’s most powerful weapon is the motion to exclude plaintiff expert testimony under Daubert. If the court rules that the epidemiological and toxicological evidence linking talc to ovarian cancer is not reliable enough for a jury to hear, every case falls — no matter how strong the individual exposure history is. The counter is the body of peer-reviewed epidemiology showing statistically significant associations between perineal talc use and ovarian cancer, the IARC classification, toxicological evidence of talc particle migration to ovarian tissue, and the methodology of plaintiff experts who rely on recognized scientific methods — not novel theories — to reach their opinions. The standard for admissibility is reliability, not certainty.
Play 2: The Specific Causation Gap. Even if general causation survives, J&J will argue that each individual plaintiff cannot prove her cancer was caused by talc rather than other risk factors — genetics, BRCA mutations, age, reproductive history, hormonal factors. The counter is a strong specific causation profile: long-term daily perineal talc use, early-onset ovarian cancer, BRCA-negative status, and minimal alternative risk factors. Board-certified gynecologic oncologists can offer specific causation opinions tying the individual’s cancer to their talc exposure through differential diagnosis — ruling out other causes and identifying talc as the substantial contributing factor.
Play 3: The Statute of Limitations Attack. J&J will argue that some plaintiffs waited too long to file — that the clock started running when they were diagnosed with cancer, or when they first heard about a possible talc-cancer link, and that the deadline has passed. The counter is the discovery rule — the legal principle that in latent injury and toxic tort cases, the statute of limitations does not start running until the plaintiff knew or reasonably should have known of both the injury and its cause. A woman diagnosed with ovarian cancer in 2015 who did not learn of the talc-cancer association until 2020 may have a filing deadline that starts in 2020, not 2015. But this is state-specific — the discovery rule’s formulation, accrual trigger, and any statute of repose that can cut off a claim even before discovery all vary by jurisdiction. In most states, the personal injury statute of limitations ranges from two to six years. The specific deadline for your claim depends on your state’s law and when you discovered (or should have discovered) the connection between your cancer and talc use. This is not something to guess about — it is something to confirm with a lawyer who can check the current law of your jurisdiction.
Play 4: The Bankruptcy Channel. J&J has already tried this three times — creating a shell entity to hold talc liability, filing that entity into Chapter 11, and attempting to use bankruptcy’s channeling injunction to force all claims into a trust at a fraction of their value. Three courts have rejected this strategy. The counter is vigilance — monitoring for any revival of the Texas Two-Step or similar corporate restructuring aimed at channeling claims away from juries and into a capped trust.
Play 5: The Global Settlement Lowball. When a mass tort defendant faces tens of thousands of cases and a mixed verdict record, it may offer a global settlement framework that pays a fraction of individual case value across the entire docket. The counter is trial readiness — the willingness and ability to try individual cases and let juries decide value, which is what keeps settlement offers honest.
The Proof Story: How These Cases Are Actually Built
Here is how a talc-ovarian cancer case is built, from the day you call to the day a number is put on the table.
Week one: the preservation letter goes out. Every record that matters — your medical records, your pharmacy history, any product containers you still hold — is identified and frozen. In the MDL context, corporate document preservation is largely handled at the leadership level, but your individual evidence is yours to protect.
The medical record is assembled. Your pathology report, your oncology treatment records, your diagnostic imaging, your surgical reports — these establish the cancer diagnosis, the histological subtype, the stage at diagnosis, the treatment course, and the prognosis. This is the foundation of damages and the starting point for specific causation.
The exposure history is documented. When did you start using talc products? How often? For how many years? Was it J&J baby powder specifically, or another brand? Did you use it for feminine hygiene? Who in your family can corroborate your usage habits? Purchase receipts, product containers, and family testimony build the exposure timeline. The stronger and more specific your exposure history — daily perineal use for 20-plus years is the gold standard — the stronger your specific causation profile.
The expert team is assembled. Epidemiologists with published credentials in talc-ovarian cancer meta-analysis provide general causation opinions. Board-certified gynecologic oncologists provide specific causation — linking your individual cancer to your specific talc use through differential diagnosis. Toxicologists explain the biological mechanism — how talc particles travel from the vagina through the reproductive tract to the ovaries, where chronic inflammation and cellular damage can promote malignant transformation. Mineralogists test product samples for asbestos contamination where available.
Discovery and depositions follow. In the MDL, corporate document discovery is largely complete, but individual cases may require supplemental discovery — J&J’s internal testing data for specific product batches, marketing strategy documents showing knowledge of cancer concerns, regulatory communications with the FDA. Depositions of J&J corporate representatives under oath are where the company’s choices are exposed.
The number is built from all of it. A life-care planner prices the cost of your past and future medical treatment. A forensic economist calculates your lost earning capacity. Non-economic damages — pain, suffering, loss of quality of life — are valued based on the severity and permanence of your injuries. Punitive damages, where supported by the concealment-and-knowledge evidence, are layered on top. The final demand is built from the medical record, the exposure history, the expert opinions, the corporate documents, and the economic models — not from a formula.
For cases involving toxic exposure more broadly — whether talc, benzene, asbestos, or chemical contamination — our toxic tort practice page walks through the framework we use to build these claims.
The Medicine: Ovarian Cancer and Talc Exposure
Ovarian cancer is one of the most devastating diagnoses a woman can receive. It is often called a “silent killer” because it frequently presents at an advanced stage — the symptoms are subtle, non-specific, and easily attributed to other causes until the disease has spread beyond the ovaries.
The biological theory connecting talc to ovarian cancer is based on the migration of talc particles from the perineal area through the reproductive tract to the ovaries. Talc particles applied to the genital area can travel through the vagina, cervix, uterus, and fallopian tubes to the ovarian surface. Once there, the particles are thought to cause chronic inflammation — a persistent immune response that creates a cellular environment favorable to malignant transformation over years or decades.
This is a latency case. The exposure — daily use of talc-based body powder for feminine hygiene — may have occurred over decades, and the cancer may not develop until years or decades after exposure began. The latency is part of what makes the statute of limitations question so important: a woman may have been exposed in her twenties and diagnosed in her fifties, with no idea that the powder she used every day was a potential cause.
The damages in these cases reflect the severity of the disease. Past and future medical treatment includes surgical intervention — often total abdominal hysterectomy with bilateral salpingo-oophorectomy — chemotherapy regimens that can last months, radiation therapy, and ongoing oncological monitoring that may continue for years or for life. Lost wages and diminished earning capacity reflect the time lost to treatment and the long-term impact of cancer and its treatment on a woman’s ability to work. Non-economic damages — physical pain, emotional distress, loss of quality of life, the fear of recurrence, the impact on intimate relationships — are severe and permanent.
Where the plaintiff has died, survival claims capture the decedent’s damages between injury and death — the pain, the fear, the suffering she endured from diagnosis through treatment to death. Wrongful death claims compensate surviving family members — spouse, children, parents — under each applicable state’s wrongful death statute, which defines who may recover and what losses are compensable. These are two separate claims, and a defense lawyer is happy to let a grieving family walk through only one door.
J&J’s Bankruptcy Strategy: The Texas Two-Step
The “Texas Two-Step” is a corporate restructuring maneuver that has become a flashpoint in mass tort law. Here is how it works — and how it failed.
A company facing massive tort liability uses a state corporate law — historically Texas’s divisional merger statute — to split itself into two entities: one that keeps the valuable business operations and assets, and one that assumes all the tort liability. The liability entity then files for Chapter 11 bankruptcy, seeking to use the bankruptcy’s channeling injunction and trust mechanism to resolve all tort claims through a capped fund — paying claimants a fraction of what their cases are worth and permanently barring them from pursuing individual lawsuits.
J&J executed this maneuver with the talc litigation. It created LTL Management LLC to hold the talc claims, and LTL filed for bankruptcy. The strategy was designed to channel 68,000-plus claims into a trust and cap J&J’s exposure — to replace jury trials with a claims-processing facility paying pennies on the dollar.
The bankruptcy court rejected it — twice. The courts found that LTL was not in genuine financial distress because J&J had backed it with a funding agreement worth billions, meaning the entity could pay its debts and had no legitimate reason to be in bankruptcy. The third attempt, using Red River Talc LLC, was dismissed on March 31, 2025, by the U.S. Bankruptcy Court for the Southern District of Texas, which found vote-solicitation irregularities and impermissible nonconsensual third-party releases.
Three attempts. Three failures. The cases are back in the tort system — which is exactly why J&J is now trying the dismissal motion instead. The bankruptcy channel failed, so the company is attempting to close the litigation through the front door: a single ruling that the science does not support the claims.
Can You Still File a New Claim?
The short answer is: it depends on your state’s statute of limitations and when you discovered (or should have discovered) the connection between your cancer and talc use.
The discovery rule is the key. In most states, the statute of limitations for a personal injury claim does not begin running until the plaintiff knows or reasonably should know of both the injury and its cause. For a woman diagnosed with ovarian cancer years ago who only recently learned of the talc-cancer association, the filing deadline may start from the date of that discovery — not the date of diagnosis.
But this is not automatic. Some states apply the discovery rule more generously than others. Some have a statute of repose — an outer deadline that can cut off a claim even before discovery. The specific accrual rule, the length of the limitations period, and any repose statute all depend on the law of the state whose substantive law governs your claim — typically your home state or the state where exposure and injury occurred.
The honest answer is: do not assume it is too late, and do not assume you have plenty of time. The only way to know is to have a lawyer check the current law of your jurisdiction against the specific facts of your case — when you were diagnosed, when you first learned of the talc-cancer link, and what your state’s discovery rule provides.
If your loved one has passed away from ovarian cancer and you believe talc exposure was a cause, the wrongful death statute of limitations is a separate clock with its own accrual rules — and it is often shorter than the personal injury clock. This is a deadline you cannot afford to miss.
What to Do Right Now: Your First Steps
If you used talc-based body powder for feminine hygiene and you have been diagnosed with ovarian cancer — or if someone you love was diagnosed and has since passed — here is what you should do, in order.
First, gather your medical records. Your pathology report is the single most important document. Get your complete oncology file — diagnostic imaging, surgical reports, chemotherapy records, treatment summaries. If your records are years old, request them now before provider retention schedules thin or destroy them.
Second, document your talc usage history. Write down everything you can remember: which brand or brands you used, how often, for how many years, whether you used it for feminine hygiene, who in your family can corroborate. If you still have product containers — any brand of talc-based body powder — do not discard them. Lot numbers on containers can enable batch-specific testing.
Third, talk to your family. The people who lived with you — spouse, children, siblings, parents — can corroborate your usage history. Their memories are part of the evidence, and memories fade with time. Document what they remember now.
Fourth, do not sign anything from J&J or any claims administrator. If you receive a settlement offer, a release form, a questionaire, or any communication asking you to sign away rights, do not sign without speaking to a lawyer first. The quick check that arrives with a release printed on the back is one of the oldest plays in the book — and once you sign, the door is welded shut.
Fifth, call a lawyer. Not because every lawyer can handle a mass tort product liability case — most cannot. Because the clock on your evidence and your deadline is running, and the only way to stop it is to have someone who knows this system put a preservation letter in the mail and check the law of your state.
Contact us for a free consultation. The call costs nothing. We will tell you honestly whether we can help, and if we are not the right fit for your case, we will tell you that too.
Frequently Asked Questions
Did J&J’s motion just end my case?
No. J&J filed a motion asking the court to dismiss the cases. The court has not ruled on it. Plaintiffs’ counsel are preparing responses, and the legal fight over this motion is ongoing. A motion is a request, not a ruling.
What does “dismissed with prejudice” mean?
It means a case is permanently barred and cannot be refiled. J&J is seeking this outcome because it wants to end all pending talc claims in one order, rather than fighting them individually. If the motion succeeded, affected claims would be permanently extinguished.
Is the talc litigation over?
No. The litigation has been ongoing for over a decade and has survived multiple challenges — including three failed bankruptcy attempts by J&J. The dismissal motion is the company’s latest strategy, but it is not a final resolution. The MDL docket remains active, plaintiffs’ counsel are responding to the motion, and cases continue to be developed.
How long do I have to file a talc cancer claim?
The deadline depends on your state’s statute of limitations and when you discovered (or should have discovered) the connection between your cancer and talc use. Most states have personal injury statutes of limitations ranging from two to six years, but the discovery rule may extend the clock in latent injury cases. If your loved one has passed, the wrongful death deadline is often shorter. Do not assume it is too late — and do not assume you have time to wait. Confirm the deadline with a lawyer who can check your state’s current law.
Can I still file a new claim if I was just diagnosed?
If you were recently diagnosed with ovarian cancer and you used talc-based body powder for feminine hygiene over a period of years, you may be eligible to file a claim. The specific eligibility depends on your state’s statute of limitations, your exposure history, your cancer diagnosis, and the strength of your specific causation evidence. A case evaluation can determine whether you have a viable claim.
What evidence do I need to preserve?
Your medical records — especially your pathology report and oncology treatment records — are the foundation. Your talc product usage history, including any product containers you still have with visible lot numbers, is critical for the exposure element. Family testimony corroborating your usage habits strengthens your case. If you have physical product containers, do not discard them.
What is the J&J Texas Two-Step bankruptcy?
It is a corporate restructuring strategy J&J used to try to channel all talc claims into a bankruptcy trust, where claimants would be paid a fraction of their case value and barred from pursuing individual lawsuits. J&J created a shell entity to hold the liability and filed that entity into Chapter 11. The bankruptcy courts rejected this strategy three times — most recently on March 31, 2025 — finding that the entity was not in genuine financial distress and that the strategy improperly attempted to use bankruptcy to resolve claims against a solvent company.
How much is my talc cancer case worth?
Case value depends on your specific facts: the duration and frequency of your talc use, your cancer stage and treatment trajectory, your age and earning capacity, the strength of your specific causation evidence, and the governing state law — including whether your state caps damages. Verdicts in comparable talc cases have ranged from substantial six-figure settlements to multi-million-dollar individual awards to aggregate billion-dollar judgments. No lawyer can honestly promise a specific number without reviewing your medical records, your exposure history, and the law of your state.
Will I have to go to trial?
Most mass tort cases settle before trial, but trial readiness is what makes settlement offers honest. If your case is strong and your counsel is prepared to try it, the pressure of a potential jury verdict is what drives fair settlement value. The decision to settle or try a case is always yours — not the lawyer’s.
If my mother died from ovarian cancer and used talc, can our family still file?
Possibly, if the statute of limitations has not expired. Wrongful death claims have their own deadlines, which are often shorter than personal injury deadlines and vary by state. If your mother’s death was recent — within the last one to several years, depending on your state — you may still have time. A personal representative may need to be appointed by the court to bring the claim on behalf of the estate and the family. This is a time-sensitive question that requires immediate legal attention.
Why This Firm
We are not going to tell you we have already won your case, because we have not seen your case. We are not going to tell you we are the biggest firm handling talc litigation, because we are not. What we are going to tell you is what we actually do and who we actually are.
Ralph Manginello has been licensed to practice law since November 6, 1998 — 27-plus years. He is admitted to the U.S. District Court for the Southern District of Texas, including its Bankruptcy Court. Before he was a lawyer, he was a journalist. That training matters in a mass tort case because the evidence that wins these cases is found in documents — internal corporate memos, testing data, marketing strategy records — and a lawyer who was trained to read documents and find the story is a lawyer who finds the evidence others miss. Ralph handles catastrophic injury and wrongful death cases, and he does not hesitate to take a case to trial when the other side refuses to offer what it is worth.
Lupe Peña spent years inside a national insurance-defense firm. He sat in the rooms where adjusters and their software decided how to deny, delay, and devalue claims. He knows how claim valuation works from the inside — how reserves are set, how IME doctors are selected, how surveillance is used, how delay tactics run out the clock. He now uses that knowledge for injured people. Lupe is fluent in Spanish and conducts full client consultations in Spanish without an interpreter.
We work on contingency. That means we do not get paid unless we win your case. The fee is 33.33% before trial and 40% if the case goes to trial. The first consultation is free. You can call us 24 hours a day, 7 days a week — and you will reach a live staff member, not an answering service.
Past results depend on the facts of each case and do not guarantee future outcomes. The talc litigation is contested and evolving. No outcome is guaranteed. What we can promise is that we will tell you the truth about your case — what it is worth, what the risks are, and whether we are the right firm for you — and if we are not, we will tell you that too.
We handle toxic tort and product liability cases nationwide, working with local counsel and pro hac vice admission where required. You do not need to be in Texas to call us. If you or someone you love used talc products and developed ovarian cancer, the time to act is now — not because the dismissal motion is going to end your case tomorrow, but because the evidence that proves your case is on a clock, and the deadline that governs your claim is running.
Hablamos Español.
Call 1-888-ATTY-911. The consultation is free. The call is confidential. And the clock does not stop while you decide.